Jun 06, 2023 / 01:00PM GMT
Dylan Becker - William Blair - Analyst
I think we're about at the 8:00 hour. So thank you, everybody, for joining us. My name is Dylan Becker; I'm the analyst here that covers vertical software and, as a function of that, covers Enfusion. We have Oleg Movchan, the CEO; and Brad Herring, the CFO of the business here.
I do have to start by saying all of the necessary disclosures can be found at williamblair.com.
But with that out of the way, thank you, gentlemen, for joining us today. And maybe since there are a good bit of generalists here, Oleg, starting off high level, kind of level set the original idea of what you guys were trying to do with Enfusion, how you've seen the business evolve, and how you're thinking about the opportunity for frontend --
Oleg Movchan - Enfusion, Inc. - CEO
So basically, the idea was to build a multi-tenant software architecture that allows for scale. The founders did many different things. They consulted for Citadel. We met when I was at 3G Capital many years ago in 2002, and they worked on a portfolio management
Enfusion Inc at William Blair Growth Stock Conference Transcript
Jun 06, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers